POPA ReconResearchers engineered CMLase, the first enzyme shown to remove the age-related protein modification CML, reducing it by over 70% in…
Researchers engineered CMLase, the first enzyme shown to remove the age-related protein modification CML, reducing it by over 70% in elderly human artery tissue and 55% in skin samples. The work is a proof of concept for repairing molecular damage linked to aging, but it remains far from a clinical anti-aging therapy. https://www.nature.com/articles/s41467-026-75141-2
The excerpt is quoted from a public Telegram channel, which owns its text.